Propagermanium for treating myeloma bone disease and other bone disorders
AssigneeSurroMed, Inc.
InventorAnthony Allison
Life of this patent
Estimating the term…
Abstract
Methods and pharmaceutical compositions containing the organic germanium polymer propagermanium are used for treating bone disorders such as myeloma bone disease, multiple myeloma, Paget's disease, secondary bone cancers, and periodontitis.
Claims14
A method for treating a subject having a bone disorder, comprising administering to said subject a pharmaceutical composition comprising a therapeutically effective amount of propagermanium.
A method for inhibiting bone resorption in a subject comprising administering to said subject a therapeutically effective amount of propagermanium.
A dental composition comprising a therapeutically effective amount of propagermanium.
Dependencies are inferred from the claim text.